Intriguingly, we observed that hyper-editing of AZIN1 RNA was observed to be an independent risk factor associated with LNM; highlighting its potential clinical relevance as an identification of high-risk populations harboring LNM in GC patients. Here, AZIN1 is linked to gastric cancer.